Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) — via IBN — Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY) and a cutting-edge innovator at the intersection of AI, clinical research, and personalized wellness, today announced the appointment of Dr. Joel Gagnier, BA, ND, MSc, PhD, as Chief Science Officer (CSO). This strategic … Read more